Keyphrases
Cyclophosphamide
100%
Adriamycin
100%
Next-generation Sequencing
100%
Chemotherapy
100%
Breast Cancer Cells
100%
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
50%
Cancer Types
50%
Transcriptome Analysis
50%
Drug Target
50%
Functional Role
50%
Differential Expression
50%
Signature Genes
50%
Paclitaxel
50%
Total RNA Sequencing
50%
Omani
50%
Treatment Choice
50%
Breast Cancer
50%
Breast Cancer Patients
50%
Increased Incidence
50%
Resistant Breast Cancer
50%
Luminal B
50%
Resistant Cells
50%
Advanced Breast Cancer
50%
Neoadjuvant Chemotherapy
50%
BT-474
50%
Breast Cancer Cell Lines
50%
Complete Clinical Response
50%
MCF-7
50%
Complete Pathological Response
50%
Resistance Mechanisms
50%
Breast Cancer Subtypes
50%
Incidence Rate
50%
Aggressive Disease
50%
Resistance to Chemotherapy
50%
Response to Treatment
50%
MDA-MB-231
50%
Triple Negative
50%
Medicine and Dentistry
Breast Cancer
100%
Next Generation Sequencing
100%
Cancer Cell
100%
Doxorubicin
50%
6 Diazo 5 Oxonorleucine
50%
Cyclophosphamide
50%
Cell Line
50%
Clustered Regularly Interspaced Short Palindromic Repeat
25%
Antiinfective Agent
25%
Breast Cancer Cell Line
25%
Diseases
25%
Gene Expression Profiling
25%
Paclitaxel
25%
RNA Sequence
25%
Neoadjuvant Chemotherapy
25%
Malignant Neoplasm
25%
INIS
genes
100%
breasts
100%
cancer
100%
chemotherapy
100%
drugs
66%
patients
50%
adriamycin
33%
cyclophosphamide
33%
luminal
33%
proposals
16%
rna
16%
females
16%
surgery
16%
diseases
16%